Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

India's Ajanta Pharma gains on Biocon weight-loss drug marketing pact

** Ajanta Pharma's AJPH.NS stock rises 3.7% to 2,771 rupees

** Drugmaker signs in-licensing pact with Biocon BION.NS for marketing weight-loss drug semaglutide

** BION will supply semaglutide to AJPH for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, the Middle East and Central Asia - AJPH says

** BION up 0.5% on the day

** Avg rating of 13 analysts on AJPH at "buy"; median PT is 3,115 rupees - data compiled by LSEG

** YTD, AJPH down 5.7% vs pharma index's .NIPHARM 2.1% drop

 (Reporting by Kashish Tandon in Bengaluru)

 ((Kashish.tandon@thomsonreuters.com))

Recent news on Ajanta Pharma

See all news